Neoandrographolide Composition for Multi-Target Diabetes Management
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for diabetes, particularly type 2 diabetes, are inadequate in effectively lowering blood sugar, blood lipid levels, improving liver function, and renal function, leading to potential complications such as cardiovascular disease, kidney failure, and blindness.
Innovation Solution
The use of Neoandrographolide, extracted from Andrographis paniculata, is employed to prepare a composition that can be administered to lower blood sugar, blood lipid levels, improve liver function, and enhance renal function, with effective dosages ranging from 0.5 mg/kg to 20 mg/kg, either alone or in combination with other active ingredients.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for diabetes are used, then blood sugar levels can be controlled to some extent, but they are inadequate in effectively lowering blood sugar, blood lipid levels, improving liver function, and renal function simultaneously
Solution Approach 1:
The patent applies the universality principle by using Neoandrographolide as a single active ingredient that simultaneously performs multiple functions: lowering blood sugar, reducing blood lipid levels, improving liver function, and enhancing renal function. This multi-functional approach resolves the contradiction by providing comprehensive diabetes treatment with one compound rather than requiring multiple separate treatments for each symptom.
Solution Approach 2:
The patent employs composite materials by formulating Neoandrographolide in combination with other ingredients (such as excipients, carriers, or complementary compounds) to create a composite pharmaceutical composition. This composite formulation enhances the overall therapeutic effect, stability, and bioavailability, thereby improving treatment reliability while maintaining multi-functionality.
2Reliability
If Neoandrographolide is administered at higher doses to improve therapeutic effect, then blood sugar and lipid levels are lowered more effectively, but potential side effects and toxicity may increase
Solution Approach 1:
The patent applies parameter changes by optimizing the dosage range of Neoandrographolide to achieve maximum therapeutic effect while minimizing toxicity. The specified effective dose range of 0.5-20 mg/kg represents an optimized parameter that balances efficacy and safety. This resolves the contradiction by identifying a precise dosage window where the compound is most effective without causing harmful side effects.
Solution Approach 2:
The patent uses intermediaries such as excipients, carriers, or formulation agents that facilitate the safe delivery of Neoandrographolide at effective doses. These intermediary substances help modulate the release, absorption, and distribution of the active compound, thereby maintaining therapeutic effectiveness while reducing potential toxicity and side effects.
3Reliability
If multiple separate treatments are used to address different diabetes complications, then specific symptoms can be targeted, but treatment complexity and patient compliance become problematic
Solution Approach 1:
The patent applies the merging principle by combining multiple therapeutic functions into a single pharmaceutical composition containing Neoandrographolide. Instead of requiring separate medications for blood sugar control, lipid management, liver function, and renal protection, the invention merges all these functions into one treatment regimen. This resolves the contradiction by simplifying the treatment complexity while maintaining comprehensive symptom management through the multi-functional properties of Neoandrographolide.
Data Source
AI summary
A method of using Neoandrographolide for lowering blood sugar, lowering blood lipid, improving liver function and improving renal function. The method includes preparing a composition comprising Neoandrographolide as the active ingredient, and administering the composition to lower the blood sugar or blood lipid of a user, to prevent a decrease in liver function of a user, or to improve the renal function of a user. The Neoandrographolide is the only active ingredient in the composition.